Lv1
68 积分 2025-03-14 加入
Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment
4小时前
已完结
Significance of longitudinal Epstein–Barr virus DNA combined with multipoint tumor response for dynamic risk stratification and treatment adaptation in nasopharyngeal carcinoma
9小时前
已完结
SIOPE – Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy
3天前
已完结
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial
1个月前
已完结
National Cancer System Characteristics and Prostate Cancer Outcomes: An Analysis of Global Data
1个月前
已完结
Tumor Treatment Response Guided Adaptive Dose De-escalation/Escalation Strategy for Concurrent Chemoradiotherapy of Nasopharyngeal Carcinoma
1个月前
已完结
Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities
3个月前
已完结
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma
4个月前
已完结
Risk Stratification in T4 or N3 Nasopharyngeal Carcinoma
4个月前
已关闭
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
